Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Description of key information

The study was conducted as Local Lymph Node Assay according to testing methods OECD 429 and EC B. 42. The study was performed with vertebrate animals as no full regulatory in vitro alternative is available. Based on the observations recorded in the preliminary test, the 0.5% (w/v) dose was selected as top dose for the main test. In the main assay, twenty four female CBA/CaOlaHsd mice were allocated to six groups of four animals each at test item concentrations of 0.5 % (w/v), 0.25% (w/v), 0.1% (w/v) and 0.05% (w/v). Vehicle was acetone:olive oil 4:1.

The stimulation index values were 12.6, 16.5, 4.1 and 4.7 at concentrations of 0.5 % (w/v), 0.25% (w/v), 0.1% (w/v) and 0.05% (w/v), respectively. In conclusion, under the conditions of the present assay, LZ 514, tested in a suitable vehicle, was shown to have sensitization potential (sensitizer) in the Local Lymph Node Assay. Based on these results, the test item is classified as skin sensitizer Category 1 (sub-category 1A) according to the UN GHS system.

Key value for chemical safety assessment

Skin sensitisation

Link to relevant study records
Reference
Endpoint:
skin sensitisation: in vivo (LLNA)
Type of information:
experimental study
Adequacy of study:
key study
Study period:
February - July 2014
Reliability:
1 (reliable without restriction)
Rationale for reliability incl. deficiencies:
guideline study
Qualifier:
according to guideline
Guideline:
EU Method B.42 (Skin Sensitisation: Local Lymph Node Assay)
Deviations:
no
Qualifier:
according to guideline
Guideline:
OECD Guideline 429 (Skin Sensitisation: Local Lymph Node Assay)
Deviations:
no
GLP compliance:
yes (incl. QA statement)
Type of study:
mouse local lymph node assay (LLNA)
Specific details on test material used for the study:
SOURCE OF TEST MATERIAL
- Test Substance Name: LZ 514
- Source: Lonza Ltd, Visp/Switzerland
- Lot/batch No. of test material: 5011
- Expiration date of the lot/batch: 2nd December 2017
- Manufacture date: 3rd December 2015

STABILITY AND STORAGE CONDITIONS OF TEST MATERIAL
- Storage conditions: Controlled room temperature (15-25 ºC, below 70 RH%), protected from light and humidity.
- Stability under test conditions: stable
- Safety precautions: Routine safety precautions (lab coat, gloves, safety glasses, face mask) for unknown materials were applied to assure personnel health and safety.
Species:
mouse
Strain:
other: CBA/CaOlaHsd mice
Sex:
female
Details on test animals and environmental conditions:
TEST ANIMALS
- Source: Envigo (formerly: Harlan Laboratories S.r.l.), San Pietro al Natisone (UD), Zona Industriale Azzida, 57, 33049 Italy
- Females (if applicable) nulliparous and non-pregnant: yes
- Age at study initiation: 9 weeks old (age-matched, within one week)
- Weight at study initiation: 20.2– 22.4 grams
- Housing: group caging / mice were provided with glass tunnel-tube
- Acclimation period: 13 days
- Indication of any skin lesions: no
- Water (e.g. ad libitum): tap water
- Diet (e.g. ad libitum): ssniff® SM Rat/Mouse – “Breeding & Maintenance, 15 mm, autoclavable Complete diet for rats/mice produced by ssniff Spezialdiäten GmbH (Ferdinand-Gabriel-Weg 16, D-59494 Soest, Germany)

ENVIRONMENTAL CONDITIONS
- Temperature (°C): 20.0 – 25.9°C
- Humidity (%): 24 - 79 %
- Air changes (per hr): 15-20 air exchanges/hour
- Photoperiod (hrs dark / hrs light): 12 hours daily, from 6.00 a.m. to 6.00 p.m.
Vehicle:
acetone/olive oil (4:1 v/v)
Remarks:
abbreviated as AOO
Concentration:
Based on the observations recorded in the preliminary test, the 0.5% (w/v) dose was selected as top dose for the main test.
No. of animals per dose:
6 groups with 4 animals/group
Details on study design:
In the main assay, twenty four female CBA/CaOlaHsd mice were allocated to six groups of four animals each:
- four groups received test item (formulated in AOO) at 0.5 % (w/v), 0.25% (w/v), 0.1% (w/v) and 0.05% (w/v) concentrations,
- the negative control group received the vehicle (AOO),
- the positive control group received 25 % (w/v) HCA (dissolved in AOO).
Positive control substance(s):
hexyl cinnamic aldehyde (CAS No 101-86-0)
Positive control results:
The result of the positive control substance α-Hexylcinnamaldehyde (HCA) dissolved in the same vehicle was used to demonstrate the appropriate performance of the assay. The positive control substance was examined at a concentration of 25 % in the relevant vehicle (AOO) using CBA/CaOlaHsd mice.
No mortality, cutaneous reactions or signs of toxicity were observed for the positive control substance in the study. A lymphoproliferative response in line with historic positive control data (stimulation index value of 10.4) was noted for HCA in the main experiment. This value was considered to confirm the appropriate performance of the assay. Furthermore, the DPN values observed for the vehicle and positive control substance in this experiment were within the historical control. Each treated and control group included 4 animals.
Key result
Parameter:
SI
Value:
12.6
Test group / Remarks:
test item concentration 0.5% (w/v)
Key result
Parameter:
SI
Value:
16.5
Test group / Remarks:
test item concentration 0.25% (w/v)
Key result
Parameter:
SI
Value:
4.1
Test group / Remarks:
test item concentration 0.1% (w/v)
Key result
Parameter:
SI
Value:
4.7
Test group / Remarks:
test item concentration 0.05% (w/v)

No mortality or systemic clinical signs were observed during the main study. No test item precipitate was observed on the ears of the experimental animals. There were no indications of any irritancy at the site of application. No treatment related effects were observed on the mean body weight changes in the main study.

Interpretation of results:
Category 1A (indication of significant skin sensitising potential) based on GHS criteria
Conclusions:
The stimulation index values were 12.6, 16.5, 4.1 and 4.7 at concentrations of 0.5 % (w/v), 0.25% (w/v), 0.1% (w/v) and 0.05% (w/v), respectively. In conclusion, under the conditions of the present assay, LZ 514, tested in a suitable vehicle, was shown to have sensitization potential (sensitizer) in the Local Lymph Node Assay. Based on these results, the test item is classified as skin sensitizer Category 1 (sub-category 1A) according to the UN GHS system.
Executive summary:

The study was conducted as Local Lymph Node Assay according to testing methods OECD 429 and EC B. 42. The study was performed with vertebrate animals as no full regulatory in vitro alternative is available. Based on the observations recorded in the preliminary test, the 0.5% (w/v) dose was selected as top dose for the main test. In the main assay, twenty four female CBA/CaOlaHsd mice were allocated to six groups of four animals each at test item concentrations of 0.5 % (w/v), 0.25% (w/v), 0.1% (w/v) and 0.05% (w/v). Vehicle was acetone:olive oil 4:1.

The stimulation index values were 12.6, 16.5, 4.1 and 4.7 at concentrations of 0.5 % (w/v), 0.25% (w/v), 0.1% (w/v) and 0.05% (w/v), respectively. In conclusion, under the conditions of the present assay, LZ 514, tested in a suitable vehicle, was shown to have sensitization potential (sensitizer) in the Local Lymph Node Assay. Based on these results, the test item is classified as skin sensitizer Category 1 (sub-category 1A) according to the UN GHS system.

Endpoint conclusion
Endpoint conclusion:
adverse effect observed (sensitising)
Additional information:

Source: GLP-report

Respiratory sensitisation

Endpoint conclusion
Endpoint conclusion:
no study available

Justification for classification or non-classification

Based on the results of this study, the test item is classified as skin sensitizer Category 1 (sub-category 1A) according to the UN GHS system.